The present invention relates to the use of leukaemia inhibitory factor (LIF), alone or in combination with other cytokines such as interleukin-6 (IL-6) and/or transforming growth factor .alpha.(TGF.alpha.) and/or fibroblast growth factor (FGF), to stimulate the proliferation and/or differentiation of...http://www.google.fr/patents/US5435999?utm_source=gb-gplus-shareBrevet US5435999 - Proliferative action of leukaemia inhibitory factor on satellite cells
Proliferative action of leukaemia inhibitory factor on satellite cells
